Device Trial Radar · NCT02905617
Post Market Clinical Experience Study of Sientra 207 Breast Implants
Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
113
Actual
Start
Aug 2016
Primary completion
Jul 15, 2020
Study completion Jul 15, 2020
Sponsor
- Lead sponsor
- Tiger Biosciences, LLC.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Sep 19, 2016
Design
- Study type
- Observational
- Who can join
- Female only, from 22 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
A 12-month study to evaluate the clinical experience with Sientra 207 Silicone Gel Breast Implants
Conditions
- Breast Augmentation
- Breast Revision-Augmentation
Interventions
Sientra 207 Silicone Gel Breast ImplantDevice
The Sientra 207 Silicone Gel Breast Implant is a textured, round device with high-strength cohesive plus (HSC+) silicone gel fill.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Investigator Overall Satisfaction QuestionnaireTime frame: 3 months
- Investigator Overall Satisfaction QuestionnaireTime frame: 6 months
- Investigator Overall Satisfaction QuestionnaireTime frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Sientra, Inc.
Santa Barbara, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.